Is Qingyuan Moksha Biotechnology Co., Ltd. FDA approved?

Qingyuan Moksha Biotechnology Co., Ltd. holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.

What drugs does Qingyuan Moksha Biotechnology Co., Ltd. make?

2 products are listed under Qingyuan Moksha Biotechnology Co., Ltd. in the openFDA NDC Directory, most often as liquid; shampoo. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Qingyuan Moksha Biotechnology Co., Ltd.

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 0
Active NDC listings: 2
Live patents: 0
Countries: 0

Catalogue

Drug listings by form and route

2 active NDC listings: 2 human otc drug. By marketing category: OTC MONOGRAPH DRUG 2.

Dosage form	NDCs
liquid	1
shampoo	1

Route	NDCs
cutaneous	2

Labeller name on the listing	NDCs
qingyuan moksha biotechnology co., ltd.	2

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
Aavini Double Layer Brightening Spot Correcting Essence Oil	Aavini Double Layer Brightening Spot Correcting Essence Oil	liquid, cutaneous	85004-001OTC MONOGRAPH DRUG
EASYES ANTI DANDRUFF AND ANTI HAIR THINNING SHAMP00	EASYES ANTI DANDRUFF AND ANTI HAIR THINNING SHAMP00	shampoo, cutaneous	85004-002OTC MONOGRAPH DRUG

Enquiry

Common questions

Is Qingyuan Moksha Biotechnology Co., Ltd. FDA approved?: Qingyuan Moksha Biotechnology Co., Ltd. holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Qingyuan Moksha Biotechnology Co., Ltd. make?: 2 products are listed under Qingyuan Moksha Biotechnology Co., Ltd. in the openFDA NDC Directory, most often as liquid; shampoo. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.